Reata Pharmaceuticals Inc - Class A

Reata Pharmaceuticals Inc - Class A

RETA

Market Cap$6.57B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Reata Pharmaceuticals Inc - Class AReata Pharmaceuticals Inc - Class A-20.1--94%-2.9
$188.61

Current Fair Value

9.4% upside

Undervalued by 9.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.57 Billion
Enterprise Value$6.77 Billion
Dividend Yield$0 (0%)
Earnings per Share$-8.59
Beta1.42
Outstanding Shares41,506,900

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-20.07
PEG5.54
Price to Sales-
Price to Book Ratio86.18
Enterprise Value to Revenue288.24
Enterprise Value to EBIT-19.8
Enterprise Value to Net Income-83
Total Debt to Enterprise0.04
Debt to Equity2.87

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Reata Pharmaceuticals Inc

CEO: J. Warren Huff